The immune epitope database and analysis resource in epitope discovery and synthetic vaccine design

W Fleri, S Paul, SK Dhanda, S Mahajan, X Xu… - Frontiers in …, 2017 - frontiersin.org
The task of epitope discovery and vaccine design is increasingly reliant on bioinformatics
analytic tools and access to depositories of curated data relevant to immune reactions and …

[HTML][HTML] An overview of bioinformatics tools for epitope prediction: implications on vaccine development

RE Soria-Guerra, R Nieto-Gomez… - Journal of biomedical …, 2015 - Elsevier
Exploitation of recombinant DNA and sequencing technologies has led to a new concept in
vaccination in which isolated epitopes, capable of stimulating a specific immune response …

Evolution of neoantigen landscape during immune checkpoint blockade in non–small cell lung cancer

V Anagnostou, KN Smith, PM Forde, N Niknafs… - Cancer discovery, 2017 - AACR
Immune checkpoint inhibitors have shown significant therapeutic responses against tumors
containing increased mutation-associated neoantigen load. We have examined the evolving …

PD-1 blockade in tumors with mismatch-repair deficiency

DT Le, JN Uram, H Wang, BR Bartlett… - … England Journal of …, 2015 - Mass Medical Soc
Background Somatic mutations have the potential to encode “non-self” immunogenic
antigens. We hypothesized that tumors with a large number of somatic mutations due to …

Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

NA Rizvi, MD Hellmann, A Snyder, P Kvistborg… - Science, 2015 - science.org
Immune checkpoint inhibitors, which unleash a patient's own T cells to kill tumors, are
revolutionizing cancer treatment. To unravel the genomic determinants of response to this …

Gapped sequence alignment using artificial neural networks: application to the MHC class I system

M Andreatta, M Nielsen - Bioinformatics, 2016 - academic.oup.com
Motivation: Many biological processes are guided by receptor interactions with linear
ligands of variable length. One such receptor is the MHC class I molecule. The length …

Design of a multiepitope‐based peptide vaccine against the e protein of human COVID‐19: an immunoinformatics approach

MI Abdelmageed, AH Abdelmoneim… - BioMed research …, 2020 - Wiley Online Library
Background. A new endemic disease has spread across Wuhan City, China, in December
2019. Within few weeks, the World Health Organization (WHO) announced a novel …

[HTML][HTML] Heterogeneous tumor-immune microenvironments among differentially growing metastases in an ovarian cancer patient

A Jiménez-Sánchez, D Memon, S Pourpe… - Cell, 2017 - cell.com
We present an exceptional case of a patient with high-grade serous ovarian cancer, treated
with multiple chemotherapy regimens, who exhibited regression of some metastatic lesions …

A large fraction of HLA class I ligands are proteasome-generated spliced peptides

J Liepe, F Marino, J Sidney, A Jeko, DE Bunting… - Science, 2016 - science.org
The proteasome generates the epitopes presented on human leukocyte antigen (HLA) class
I molecules that elicit CD8+ T cell responses. Reports of proteasome-generated spliced …

NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets

M Nielsen, M Andreatta - Genome medicine, 2016 - Springer
Background Binding of peptides to MHC class I molecules (MHC-I) is essential for antigen
presentation to cytotoxic T-cells. Results Here, we demonstrate how a simple alignment step …